PCK2 and Hyperglycemia: In fact, mice overexpressing PEPCK mRNA, have elevated hepatic glucose output both in vivo and in vitro [5, 33], while overexpression of G6Pase mRNA results in hyperglycemia, hyperinsulinemia, and an over 50 % reduction in liver glycogen [34, 35].